📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRISPR-Cas9 HDR system enhances AQP1 gene expression. (2017)

First Author: Wang Z

Attributed to: Development of an effective therapeutic regime for preventing cancer recurrence after surgery using a novel viro-immunotherapeutic agent funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.22901

PubMed Identifier: 29340084

Publication URI: http://europepmc.org/abstract/MED/29340084

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 67

ISSN: 1949-2553